Codrina Ancuța

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 479 citations

Rheumatoid Disorder, Rheumatology, Tofacitinib Monotherapy +8

A phase II, randomized, double‐blind, placebo‐controlled study evaluating the efficacy and safety of MDX‐1100, a fully human anti‐CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis

Michael Yellin, I.A. Paliienko, Andra Bălănescu et al. · Arthritis & Rheumatism · 2011 · 192 citations

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study

Muriel Elhaï, Marouane Boubaya, Oliver Distler et al. · Annals of the Rheumatic Diseases · 2019 · 184 citations · Full text

Determinants of discordance in patients' and physicians' rating of rheumatoid arthritis disease activity

Nasim A. Khan, Horace J. Spencer, Esam Abda et al. · Arthritis Care & Research · 2011 · 178 citations

Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)

Ariane L. Herrick, Xiaoyan Pan, Sébastien Peytrignet et al. · Annals of the Rheumatic Diseases · 2017 · 134 citations · Full text